Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 11:35 PM
Ignite Modification Date: 2025-12-25 @ 9:24 PM
NCT ID: NCT00245856
Description: None
Frequency Threshold: 5
Time Frame: None
Study: NCT00245856
Study Brief: Treatment of Upper Extremity Deep-Vein Thrombosis
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Dalteparin + Warfarin 200 units per kg with transition Warfarin titrated to INR 2-3 This arm was completed and new treatment regimen was substituted for the remainder of the study. None None 1 28 0 28 View
Dalteparin Only 200 units/kg for one month At month one, dosage reduction based on weight None None 1 39 2 39 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Bleeding None Blood and lymphatic system disorders None View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Thrombocytopenia None Blood and lymphatic system disorders None View